K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

For Actos victims, pharmaceutical litigation may be appropriate

With seemingly more and more people in Ohio struggling with type 2 diabetes, an effective and reliable form of treatment can be life changing for sufferers. In addition to diet modification, prescription medication is a popular tool for people to control their symptoms. Unfortunately, the type 2 diabetes medication Actos may cause more harm than good and is suspected of causing serious drug injuries. For victims, pharmaceutical litigation may be an appropriate option.

Actos is specifically indicated for use in controlling blood sugar level in those who suffer from type 2 diabetes. While it may have controlled blood sugar, it was later discovered that patients who took this medication for at least one year also increased their risk for bladder cancer by an astounding 40 percent. This announcement followed Actos being yanked from several overseas markets.

Actos was never pulled from markets in the United States and is still being manufactured and distributed by Takeda Pharmaceuticals North America Inc. Actos is not always manufactured as a single medication. It is also combined with other medications and then distributed under different names. These medications include Duetact and Actoplus Met.

Ohio patients who have developed bladder cancer after taking Actos have developed painful and serious symptoms such as frequent and painful urination. It can be devastating to take a medication to treat one medical issue only to later develop an even more serious and life-threatening disease. We understand that drug injuries can turn a victim’s life upside down and believe that every victim has the right to seek just compensation for his or her related drug injuries. Although pharmaceutical litigation can seem overwhelming at first, we encourage readers to explore more information on our website to better understand how appropriate this choice may be.

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now